Skip to main content
SLAS2024 Main banner
Sartorius Ad
Back

René M. Overmeer, PhD

HUB Organoids, Utrecht, Netherlands

Dr. Overmeer received his PhD in Biology from the Leiden University Medical Center on a molecular study of DNA damage repair. He subsequently moved to University Medical Center Utrecht to do his postdoc work studying Ras/Rap cancer signaling. During this period, he started working with adult stem cell Patient Derived Organoids and developed the first drug screens together with the group of Hans Clevers. In 2015, René moved to HUB Organoids to further develop organoids toward a reliable drug screening platform. In 2020, he became head of the newly formed Assay development and Automation group, and in 2023 he transitioned to the role of Principle Scientist to focus on the technical, biological and data analysis challenges involved in high-throughput organoid screening.

Disclosure information not submitted.

Presentation(s):